Novalis LifeSciences — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
BlueWhale Bio develops manufacturing technologies for cell-based therapies, focusing on cell activation and expansion in early-stage processing to improve efficiency and reduce costs.
BiotechDeep TechMedical DevicesPhiladelphia, US
Peter Keller(Executive Officer, Director)in
BoardElaine Heron(Director)Paula Cannon(Director)Beate Mueller-Tiemann(Director)
Board seatPaul Meister· per SEC Form D
Co-investorsAscendo VenturesBaselayer CapitalCardanoGhaf Capital Partnersgumi IncPRIMAL CAPITAL+2 more
Flywheel provides a platform for organizing, managing, and sharing medical imaging data.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesMinneapolis, US
Brian Wandell(Co-founder)Gunnar Schaefer(Co-founder)inColby Moosman(Executive Officer)inMatthew D. Michela(Executive Officer, Director)inSarah Fazio(Executive Officer)Jim Olson(Executive Officer)in
Board seatMarijn DekkersPaul MeisterDevin Leake· per SEC Form D
Co-investors8VCAlumni VenturesBeringeaGreat North VenturesIntuitive VenturesiSelect Fund+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

















